全文获取类型
收费全文 | 165755篇 |
免费 | 33543篇 |
国内免费 | 2454篇 |
专业分类
耳鼻咽喉 | 5340篇 |
儿科学 | 5752篇 |
妇产科学 | 2703篇 |
基础医学 | 5479篇 |
口腔科学 | 1778篇 |
临床医学 | 28042篇 |
内科学 | 51401篇 |
皮肤病学 | 7764篇 |
神经病学 | 16183篇 |
特种医学 | 6884篇 |
外科学 | 43165篇 |
综合类 | 470篇 |
现状与发展 | 72篇 |
一般理论 | 8篇 |
预防医学 | 8268篇 |
眼科学 | 3717篇 |
药学 | 1957篇 |
中国医学 | 83篇 |
肿瘤学 | 12686篇 |
出版年
2024年 | 519篇 |
2023年 | 4870篇 |
2022年 | 1364篇 |
2021年 | 3564篇 |
2020年 | 6269篇 |
2019年 | 2559篇 |
2018年 | 7825篇 |
2017年 | 7613篇 |
2016年 | 8702篇 |
2015年 | 8774篇 |
2014年 | 15995篇 |
2013年 | 16313篇 |
2012年 | 6635篇 |
2011年 | 6651篇 |
2010年 | 10991篇 |
2009年 | 14772篇 |
2008年 | 6782篇 |
2007年 | 5068篇 |
2006年 | 7516篇 |
2005年 | 4733篇 |
2004年 | 3932篇 |
2003年 | 2858篇 |
2002年 | 2948篇 |
2001年 | 3897篇 |
2000年 | 3111篇 |
1999年 | 3349篇 |
1998年 | 3819篇 |
1997年 | 3599篇 |
1996年 | 3504篇 |
1995年 | 3307篇 |
1994年 | 2041篇 |
1993年 | 1654篇 |
1992年 | 1470篇 |
1991年 | 1498篇 |
1990年 | 1141篇 |
1989年 | 1244篇 |
1988年 | 1092篇 |
1987年 | 932篇 |
1986年 | 952篇 |
1985年 | 798篇 |
1984年 | 646篇 |
1983年 | 609篇 |
1982年 | 618篇 |
1981年 | 519篇 |
1980年 | 464篇 |
1979年 | 368篇 |
1978年 | 402篇 |
1977年 | 479篇 |
1975年 | 326篇 |
1972年 | 331篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
45.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
46.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
47.
48.
49.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
50.